Skip to main content
. 2013 Mar 25;4(4):397–401. doi: 10.1021/ml300472n

Figure 1.

Figure 1

(a) Arylpiperazine lead, showing HB interaction between its 4-acetyl group and the putative target. (b) Design of piperazine analogues, via replacement of acetyl with oxazole or benzoxazole. (c) Compound 41, showing its HB interactions with the putative target.